Skip to content

California Stem Cell Treatment Center, Inc. v. United States

Petition for certiorari denied on October 14, 2025

Docket No. Op. Below Argument Opinion Vote Author Term
24-1189 9th Cir. N/A N/A N/A N/A OT 2025

Issues: (1) Whether stem cells removed, isolated, and then reimplanted in a patient’s own stem cells to promote natural healing via surgical procedure are “drugs” subject to regulation under the Food Drug and Cosmetic Act; and (2) whether, if so, the Food and Drug Administration had a lawful basis for an enforcement action to prevent prevent physicians from undertaking the procedure given the FDA's own “same surgical procedure” exception to the Act.

DateProceedings and Orders (key to color coding)
02/11/2025Application (24A784) to extend the time to file a petition for a writ of certiorari from March 20, 2025 to May 19, 2025, submitted to Justice Kagan.
02/14/2025Application (24A784) granted by Justice Kagan extending the time to file until May 19, 2025.
05/19/2025Petition for a writ of certiorari filed. (Response due June 20, 2025)
06/09/2025Waiver of right of respondent United States to respond filed.
06/17/2025DISTRIBUTED for Conference of 9/29/2025.
06/18/2025Motion for leave to file amicus brief filed by Goldwater Institute. (Distributed)
06/20/2025Brief amicus curiae of Association of American Physicians and Surgeons filed. (Distributed)
10/06/2025DISTRIBUTED for Conference of 10/10/2025.
10/14/2025Motion for leave to file amicus brief filed by Goldwater Institute DENIED.
10/14/2025Petition DENIED.